BCAN’s Bladder Cancer Matters Podcast Featuring BCC: Canadian Perspectives on Bladder Cancer

Does that mean you can’t have bladder cancer?

We are honored to work with Jonathan to share the story of his bladder cancer diagnosis. Through months of cystoscopies, surgeries and finally, BCG treatments, Jonathan decided to capture the ups and downs of hisRead more

Join us for this very special podcast on Mother’s Day as we talk to mom Lisa about her experience being a caregiver to her two sons, Matteo and Nicco, while they both battled cancers atRead more

Jonathan remembers the first time he saw blood in his urine. It was his and Mandy’s anniversary. We are honoured to work with Jonathan and his wife, Mandy, to share the story of his bladderRead more

By: Tom Eremondi Read time: 3.5 minutes Admittedly old school, Gerry Ross’ approach to dealing with a local walk sponsor nurtured and enhanced the relationship to a surprising level. This story, however, dates back aboutRead more

Read time: 2 minutes We were so pleased to see one of our new Peer Support Volunteers, Gervais  Fournier, featured in this New Normal, Same Cancer news story, seen last month in the Le JournalRead more

Subscribe today! Our May newsletter is filled with lots of initiatives to create awareness for bladder cancer including blogs, podcasts, helpful facts, webinars and more. Bladder cancer is the 5th most common cancer in Canada andRead more

Uncertain times are upon us, around the world, as we globally respond to the coronavirus (COVID-19) that is affecting us all on some level. Many members of our bladder cancer community are directing questions our way aboutRead more

(The following content is sourced from various sites advising on the coronavirus. For more information, please see the end of this article for additional resources. Photo Credit: CDC) As news of the coronavirus (COVID-19) continues toRead more

IMPORTANT UPDATE – March 9, 2020 Bladder Cancer Canada (BCC) and its Medical Advisory Board were advised by Merck Canada in November 2019 that they would continue to face challenges in the supply of the TICERead more

In a recent press release, Janssen Pharmaceutical Companies of Johnson & Johnson have announced that they have received approval from Health Canada for BALVERSA™ (erdafitinib), the first FGFR Kinase inhibitor for the treatment of patientsRead more

Bladder Cancer Canada was recently reviewed by Charity Intelligence, an independent organization that researches Canadian charities so that donors can be well informed and give intelligently.  Of the 750 charities that Charity Intelligence has reviewed,Read more

As the holiday season approaches, there’s a special opportunity to spread joy while making a real impact.

Learn about the three most common types of urinary diversions used in Canada.

Our volunteers give their time, compassion, and dedication to support bladder cancer patients.

A new support group for anyone whose loved one has been affected by bladder cancer.

Join us on October 22 to learn more about how to navigate life with and beyond a bladder cancer diagnosis.